| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neuropace Inc (NPCE) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 36 sells. NPCE is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.24M | $62.46M | - | |
| Dir | 593.4K | $11.45M | - | |
| CFO | 131.6K | $2.54M | - | |
| CEO | 103.1K | $1.99M | - | |
| Other | 78.7K | $1.52M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2025 | Orbimed Advisors LLC67 | 10% Owner | Sell | 168,136 | $15.85 | $2,665,332.88 | -2.5% | -41.5% | - | |
| Feb 21, 2025 | Morrell Martha59 | Chief Medical Officer | Sell | 78,334 | $13.72 | $1,074,844.31 | -48.9% | +29.8% | +4.1% | |
| Feb 20, 2025 | Kck Ltd. | 10% Owner | Sell | 5,270,845 | $9.40 | $49,545,943.00 | -100% | +27.4% | +0.8% | |
| Jan 30, 2025 | Morrell Martha59 | Chief Medical Officer | Sell | 300 | $15.00 | $4,500.00 | -0.2% | -17.6% | +6.6% | |
| Jan 24, 2025 | Morrell Martha59 | Chief Medical Officer | Sell | 3,200 | $15.01 | $48,032.00 | -3.5% | -23.4% | +13.8% | |
| Oct 25, 2024 | Kck Ltd. | 10% Owner | Sell | 224,138 | $5.45 | $1,221,927.08 | -2.0% | +120.8% | +65.0% | |
| Oct 22, 2024 | Kck Ltd. | 10% Owner | Sell | 4,082 | $6.09 | $24,853.26 | - | +117.7% | +80.7% | |
| Oct 21, 2024 | Kck Ltd. | 10% Owner | Sell | 8,598 | $6.21 | $53,370.50 | - | +110.6% | +74.0% | |
| Oct 17, 2024 | Kck Ltd. | 10% Owner | Sell | 46,426 | $6.53 | $303,366.79 | - | +87.8% | +62.9% | |
| Oct 2, 2024 | Kck Ltd. | 10% Owner | Sell | 39,684 | $6.92 | $274,713.90 | - | +61.5% | +50.5% |